Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1973 3
1974 1
1975 3
1976 3
1977 1
1978 3
1979 5
1980 6
1981 13
1982 8
1983 15
1984 13
1985 11
1986 10
1987 10
1988 13
1989 13
1990 22
1991 15
1992 13
1993 17
1994 23
1995 25
1996 12
1997 15
1998 10
1999 13
2000 17
2001 9
2002 15
2003 11
2004 13
2005 29
2006 19
2007 19
2008 19
2009 9
2010 9
2011 14
2012 16
2013 20
2014 17
2015 15
2016 15
2017 10
2018 8
2019 7
2020 10
2021 6
2022 6
2023 4
2024 5
2025 4
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

582 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure.
Jeppesen PB, Pertkiewicz M, Messing B, Iyer K, Seidner DL, O'keefe SJ, Forbes A, Heinze H, Joelsson B. Jeppesen PB, et al. Gastroenterology. 2012 Dec;143(6):1473-1481.e3. doi: 10.1053/j.gastro.2012.09.007. Epub 2012 Sep 11. Gastroenterology. 2012. PMID: 22982184 Clinical Trial.
Parenteral support was reduced if 48-hour urine volumes exceeded baseline values by 10%. ...Treatment with teduglutide reduced volumes and numbers of days of parenteral support for patients with SBS-IF; ClinicalTrials.gov Number, NCT00798967....
Parenteral support was reduced if 48-hour urine volumes exceeded baseline values by 10%. ...Treatment with teduglutide reduced volu …
Nutritional Support for Moderate-to-Late-Preterm Infants - A Randomized Trial.
Alexander T, Asadi S, Meyer M, Harding JE, Jiang Y, Alsweiler JM, Muelbert M, Bloomfield FH; DIAMOND Trial Group. Alexander T, et al. N Engl J Med. 2024 Apr 25;390(16):1493-1504. doi: 10.1056/NEJMoa2313942. N Engl J Med. 2024. PMID: 38657245 Clinical Trial.
Each infant was assigned to three interventions or their comparators: intravenous amino acid solution (parenteral nutrition) or dextrose solution until full feeding with milk was established; milk supplement given when maternal milk was insufficient or mother …
Each infant was assigned to three interventions or their comparators: intravenous amino acid solution (parenteral nutrition …
Early versus late parenteral nutrition for critically ill term and late preterm infants.
Moon K, Athalye-Jape GK, Rao U, Rao SC. Moon K, et al. Cochrane Database Syst Rev. 2020 Apr 8;4(4):CD013141. doi: 10.1002/14651858.CD013141.pub2. Cochrane Database Syst Rev. 2020. PMID: 32266712 Free PMC article.
BACKGROUND: Recently conducted randomised controlled trials (RCTs) suggest that late commencement of parenteral nutrition (PN) may have clinical benefits in critically ill adults and children. ...
BACKGROUND: Recently conducted randomised controlled trials (RCTs) suggest that late commencement of parenteral nutrition (PN) …
Higher versus lower amino acid intake in parenteral nutrition for newborn infants.
Osborn DA, Schindler T, Jones LJ, Sinn JK, Bolisetty S. Osborn DA, et al. Cochrane Database Syst Rev. 2018 Mar 5;3(3):CD005949. doi: 10.1002/14651858.CD005949.pub2. Cochrane Database Syst Rev. 2018. PMID: 29505664 Free PMC article.
OBJECTIVES: The primary objective is to determine whether higher versus lower intake of parenteral AA is associated with improved growth and disability-free survival in newborn infants receiving parenteral nutrition.Secondary objectives include determining wh …
OBJECTIVES: The primary objective is to determine whether higher versus lower intake of parenteral AA is associated with improved gro …
WITHDRAWN: Nutrition support for bone marrow transplant patients.
Murray SM, Pindoria S. Murray SM, et al. Cochrane Database Syst Rev. 2017 Mar 23;3(3):CD002920. doi: 10.1002/14651858.CD002920.pub4. Cochrane Database Syst Rev. 2017. PMID: 28334434 Free PMC article.
After treatment, patients can develop poor appetite, mucositis and gastrointestinal failure, leading to malnutrition. To prevent this, parenteral nutrition (PN) support is often first choice but is associated with increased risk of infection. ...AUTHORS' CONCLUSIONS …
After treatment, patients can develop poor appetite, mucositis and gastrointestinal failure, leading to malnutrition. To prevent this, pa …
Randomized controlled phase I trial for a novel peripheral parenteral nutrition formula containing dextrose, amino acids, fat emulsion, electrolytes, and FDA2000 recommendation-based vitamins.
Fukatsu K, Shineha R, Katayose S, Kawauchi Y, Nakayama M. Fukatsu K, et al. Clin Nutr ESPEN. 2022 Aug;50:41-48. doi: 10.1016/j.clnesp.2022.05.001. Epub 2022 May 13. Clin Nutr ESPEN. 2022. PMID: 35871950 Free article. Clinical Trial.
BACKGROUND & AIMS: We developed the world's first all-in-one type peripheral parenteral nutrition product containing dextrose, amino acids, fat emulsion, electrolytes and vitamins, according to the FDA 2000 recommendation. ...Participants were admi …
BACKGROUND & AIMS: We developed the world's first all-in-one type peripheral parenteral nutrition product containing dextr …
What is the evidence for the use of parenteral nutrition (PN) in critically ill surgical patients: a systematic review and meta-analysis.
Ledgard K, Mann B, Hind D, Lee MJ. Ledgard K, et al. Tech Coloproctol. 2018 Oct;22(10):755-766. doi: 10.1007/s10151-018-1875-1. Epub 2018 Nov 14. Tech Coloproctol. 2018. PMID: 30430312
The aim of this systematic review was to evaluate the use of parenteral nutrition (PN) in critically ill surgical patients. METHODS: This review was registered with PROSPERO (CRD42017079567). ...RESULTS: Fourteen RCTs were identified; standard PN was compared vs oth …
The aim of this systematic review was to evaluate the use of parenteral nutrition (PN) in critically ill surgical patients. ME …
Efficacy and safety of intradialytic parenteral nutrition using ENEFLUID in malnourished patients receiving maintenance hemodialysis: An exploratory, multicenter, randomized, open-label study.
Kabasawa H, Hosojima M, Kanda E, Nagai M, Murayama T, Tani M, Kamoshita S, Kuroda A, Kanno Y. Kabasawa H, et al. PLoS One. 2024 Dec 12;19(12):e0311671. doi: 10.1371/journal.pone.0311671. eCollection 2024. PLoS One. 2024. PMID: 39666754 Free PMC article. Clinical Trial.
The objective of this study was to investigate the efficacy and safety of intradialytic parenteral nutrition (IDPN) using ENEFLUID (310 kcal, 550 mL) in mild-moderate malnutrition patients receiving maintenance hemodialysis. ...The secondary endpoints were changes …
The objective of this study was to investigate the efficacy and safety of intradialytic parenteral nutrition (IDPN) using ENEF …
Enteral versus parenteral nutrition in auto-HCT: a randomized controlled trial on clinical outcomes and gut microbiome dynamics.
Wardill HR, van Groningen LFJ, Dorraki M, Molendijk EBD, Kalter D, Da Silva Ferreira AR, Kurilshikov A, Ryan FJ, Verjans JW, Harmsen HJM, Tissing WJE, van der Velden WJFM, Blijlevens NMA. Wardill HR, et al. Support Care Cancer. 2025 Sep 19;33(10):865. doi: 10.1007/s00520-025-09882-z. Support Care Cancer. 2025. PMID: 40971058 Free PMC article. Clinical Trial.
Preclinical data suggest that enteral nutrition (EN) is superior to parenteral nutrition (TPN), minimising gut atrophy and promoting eubiosis; yet, TPN continues to be used. ...
Preclinical data suggest that enteral nutrition (EN) is superior to parenteral nutrition (TPN), minimising gut atrophy …
Nutrition support for bone marrow transplant patients.
Murray SM, Pindoria S. Murray SM, et al. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD002920. doi: 10.1002/14651858.CD002920.pub3. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2017 Mar 23;3:CD002920. doi: 10.1002/14651858.CD002920.pub4. PMID: 19160213 Updated.
After treatment, patients can develop poor appetite, mucositis and gastrointestinal failure, leading to malnutrition. To prevent this, parenteral nutrition (PN) support is often first choice but is associated with increased risk of infection. ...AUTHORS' CONCLUSIONS …
After treatment, patients can develop poor appetite, mucositis and gastrointestinal failure, leading to malnutrition. To prevent this, pa …
582 results